137 related articles for article (PubMed ID: 32735528)
21. In silico, in vitro and in vivo studies: Dibutyl phthalate promotes prostate cancer cell proliferation by activating Forkhead Box M1 and remission after Natura-α pretreatment.
Bu H; Tang S; Liu G; Miao C; Zhou X; Yang H; Liu B
Toxicology; 2023 Apr; 488():153465. PubMed ID: 36828243
[TBL] [Abstract][Full Text] [Related]
22. Forkhead box M1 (FOXM1) expression predicts disease free survival and may mediate resistance to chemotherapy and hormonotherapy in male breast cancer.
Abdeljaoued S; Bettaieb L; Nasri M; Adouni O; Goucha A; Bouzaiene H; Boussen H; Rahal K; Gamoudi A
Breast Dis; 2018; 37(3):109-114. PubMed ID: 29504520
[TBL] [Abstract][Full Text] [Related]
23. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
24. FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression.
Hu G; Yan Z; Zhang C; Cheng M; Yan Y; Wang Y; Deng L; Lu Q; Luo S
J Exp Clin Cancer Res; 2019 May; 38(1):188. PubMed ID: 31072351
[TBL] [Abstract][Full Text] [Related]
25. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
26. Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy.
Wu X; Scott H; Carlsson SV; Sjoberg DD; Cerundolo L; Lilja H; Prevo R; Rieunier G; Macaulay V; Higgins GS; Verrill CL; Lamb AD; Cunliffe VT; Bountra C; Hamdy FC; Bryant RJ
Prostate; 2019 Jul; 79(10):1079-1089. PubMed ID: 31104332
[TBL] [Abstract][Full Text] [Related]
27. A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2).
Mazzu YZ; Armenia J; Chakraborty G; Yoshikawa Y; Coggins SA; Nandakumar S; Gerke TA; Pomerantz MM; Qiu X; Zhao H; Atiq M; Khan N; Komura K; Lee GM; Fine SW; Bell C; O'Connor E; Long HW; Freedman ML; Kim B; Kantoff PW
Clin Cancer Res; 2019 Jul; 25(14):4480-4492. PubMed ID: 30996073
[TBL] [Abstract][Full Text] [Related]
28. Silencing forkhead box M1 promotes apoptosis and autophagy through SIRT7/mTOR/IGF2 pathway in gastric cancer cells.
Yu W; Cui X; Wan Z; Yu Y; Liu X; Jin L
J Cell Biochem; 2018 Nov; 119(11):9090-9098. PubMed ID: 29953672
[TBL] [Abstract][Full Text] [Related]
29. A novel peptide, 9R-P201, strongly inhibits the viability, proliferation and migration of liver cancer HepG2 cells and induces apoptosis by down-regulation of FoxM1 expression.
Bi Z; Liu W; Ding R; Wu Y; Dou R; Zhang W; Yuan X; Liu X; Xiong L; Guo Z; Mao C
Eur J Pharmacol; 2017 Feb; 796():175-189. PubMed ID: 28012972
[TBL] [Abstract][Full Text] [Related]
30. Regulation of the master regulator FOXM1 in cancer.
Liao GB; Li XZ; Zeng S; Liu C; Yang SM; Yang L; Hu CJ; Bai JY
Cell Commun Signal; 2018 Sep; 16(1):57. PubMed ID: 30208972
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of forkhead box protein M1 (FOXM1) plays a critical role in colorectal cancer.
Zhang HG; Xu XW; Shi XP; Han BW; Li ZH; Ren WH; Chen PJ; Lou YF; Li B; Luo XY
Clin Transl Oncol; 2016 May; 18(5):527-32. PubMed ID: 26370421
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas.
Maekawa A; Kohashi K; Kuda M; Iura K; Ishii T; Endo M; Nakatsura T; Iwamoto Y; Oda Y
BMC Cancer; 2016 Jul; 16():511. PubMed ID: 27439614
[TBL] [Abstract][Full Text] [Related]
33. PARI functions as a new transcriptional target of FOXM1 involved in gastric cancer development.
Zhang Y; Ye X; Chen L; Wu Q; Gao Y; Li Y
Int J Biol Sci; 2018; 14(5):531-541. PubMed ID: 29805304
[TBL] [Abstract][Full Text] [Related]
34. Forkhead box M1 (FOXM1) transcription factor is a key oncogenic driver of aggressive human meningioma progression.
Kim H; Park KJ; Ryu BK; Park DH; Kong DS; Chong K; Chae YS; Chung YG; Park SI; Kang SH
Neuropathol Appl Neurobiol; 2020 Feb; 46(2):125-141. PubMed ID: 31179553
[TBL] [Abstract][Full Text] [Related]
35. Involvement of EZH2 in aerobic glycolysis of prostate cancer through miR-181b/HK2 axis.
Tao T; Chen M; Jiang R; Guan H; Huang Y; Su H; Hu Q; Han X; Xiao J
Oncol Rep; 2017 Mar; 37(3):1430-1436. PubMed ID: 28184935
[TBL] [Abstract][Full Text] [Related]
36. Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma.
Zhang X; Lv QL; Huang YT; Zhang LH; Zhou HH
J Exp Clin Cancer Res; 2017 Aug; 36(1):105. PubMed ID: 28784180
[TBL] [Abstract][Full Text] [Related]
37. The forkhead box M1 (FOXM1) expression and antitumor effect of FOXM1 inhibition in malignant rhabdoid tumor.
Shibui Y; Kohashi K; Tamaki A; Kinoshita I; Yamada Y; Yamamoto H; Taguchi T; Oda Y
J Cancer Res Clin Oncol; 2021 May; 147(5):1499-1518. PubMed ID: 33221995
[TBL] [Abstract][Full Text] [Related]
38. Loss of Forkhead box M1 promotes erythropoiesis through increased proliferation of erythroid progenitors.
Youn M; Wang N; LaVasseur C; Bibikova E; Kam S; Glader B; Sakamoto KM; Narla A
Haematologica; 2017 May; 102(5):826-834. PubMed ID: 28154085
[TBL] [Abstract][Full Text] [Related]
39. Forkhead Box M1 promotes the growth and tube formation of human malignant meningioma cells via the aryl hydrocarbon receptor signaling pathway.
Wu Q; Zheng J; Dou C; Qi S
Folia Neuropathol; 2020; 58(3):223-236. PubMed ID: 33099292
[TBL] [Abstract][Full Text] [Related]
40. [Construction of a lentiviral vector of FoxM1 shRNA and its transfection into human prostate cancer cell lines in vitro].
Wang Y; Yao B; Zhang Y; Zhang M; Gao H; Tang J
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Aug; 35(9):1227-33. PubMed ID: 26403729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
